HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T Matsumoto Selected Research

WS 79089B

10/2001Endothelin-1 promotes vascular structural remodeling during the progression of heart failure prevention of vascular remodeling using a specific endothelin-converting enzyme inhibitor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


T Matsumoto Research Topics

Disease

38Neoplasms (Cancer)
01/2015 - 01/2000
21Infections
04/2012 - 04/2000
13Heart Failure
12/2003 - 03/2000
10Osteoporosis
01/2017 - 04/2000
9Crohn Disease (Crohn's Disease)
11/2017 - 12/2000
9Ulcerative Colitis
08/2009 - 05/2000
8Hemophilia A (Haemophilia)
09/2017 - 12/2001
8Rheumatoid Arthritis
01/2016 - 02/2000
8Urinary Tract Infections (Urinary Tract Infection)
11/2008 - 04/2000
7Bone Resorption
11/2019 - 04/2000
7Body Weight (Weight, Body)
04/2019 - 06/2000
7Hemorrhage
02/2018 - 01/2000
7Pneumonia (Pneumonitis)
04/2015 - 06/2000
7Prostatic Neoplasms (Prostate Cancer)
12/2013 - 09/2000
6Inflammation (Inflammations)
11/2016 - 09/2001
6Neoplasm Metastasis (Metastasis)
11/2014 - 06/2000
6Ulcer
11/2004 - 02/2001
5Necrosis
11/2017 - 08/2001
5Pain (Aches)
11/2017 - 09/2000
5Sepsis (Septicemia)
11/2016 - 01/2001
5Carcinoma (Carcinomatosis)
01/2015 - 01/2000
5Thrombosis (Thrombus)
01/2015 - 05/2000
5Liver Neoplasms (Liver Cancer)
07/2010 - 10/2006
5Diabetes Mellitus
11/2006 - 01/2000
5Pathologic Constriction (Stenosis)
11/2004 - 01/2000
4Osteoarthritis
03/2018 - 10/2008
4Disseminated Intravascular Coagulation
04/2015 - 05/2000
4Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
08/2013 - 02/2000
4Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
04/2013 - 08/2001
4Hypertension (High Blood Pressure)
12/2008 - 01/2000
4Osteonecrosis (Kienbock's Disease)
03/2006 - 09/2000
4Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
12/2005 - 12/2000
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2003 - 03/2001
4Myocardial Infarction
02/2003 - 03/2000
4Fibrosis (Cirrhosis)
11/2001 - 09/2000
4Infarction (Infarctions)
09/2001 - 01/2000
4Hypersensitivity (Allergy)
03/2001 - 04/2000
3Dermatomyositis (Dermatopolymyositis)
03/2020 - 11/2002
3Carcinogenesis
04/2019 - 06/2000
3Esophageal Neoplasms (Esophageal Cancer)
11/2014 - 01/2007
3Disease Progression
11/2014 - 01/2000
3Hypercalcemia (Milk Alkali Syndrome)
03/2012 - 06/2000
3Myocardial Ischemia (Ischemic Heart Diseases)
04/2010 - 04/2000
3Glioma (Gliomas)
05/2008 - 08/2001
3Stomach Neoplasms (Stomach Cancer)
08/2007 - 07/2000
3Abdominal Aortic Aneurysm
12/2006 - 07/2000
3Colorectal Neoplasms (Colorectal Cancer)
08/2005 - 06/2000
3Small Cell Lung Carcinoma (Small Cell Lung Cancer)
08/2004 - 03/2000
3Asthma (Bronchial Asthma)
04/2004 - 04/2000

Drug/Important Bio-Agent (IBA)

12Pharmaceutical PreparationsIBA
11/2017 - 02/2000
10Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2003 - 02/2000
9CytokinesIBA
06/2005 - 06/2000
9AntigensIBA
09/2001 - 01/2000
8Biomarkers (Surrogate Marker)IBA
11/2019 - 03/2000
8Factor VIII (Coagulation Factor VIII)IBA
09/2017 - 12/2001
8Interleukin-6 (Interleukin 6)IBA
11/2016 - 01/2000
8Proteins (Proteins, Gene)FDA Link
07/2013 - 04/2000
8Peptides (Polypeptides)IBA
07/2013 - 03/2000
7Messenger RNA (mRNA)IBA
12/2010 - 03/2000
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2008 - 03/2001
7SteroidsIBA
03/2006 - 09/2000
6AntibodiesIBA
11/2017 - 07/2000
6Cisplatin (Platino)FDA LinkGeneric
08/2004 - 01/2001
6Anti-Infective Agents (Microbicides)IBA
05/2001 - 04/2000
5Immunoglobulins (Immunoglobulin)IBA
12/2018 - 03/2001
5AndrogensIBA
12/2013 - 06/2000
5Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
06/2012 - 02/2001
5Endothelin-1 (Endothelin 1)IBA
04/2010 - 01/2000
5EnzymesIBA
10/2001 - 02/2000
4Diphosphonates (Bisphosphonates)IBA
11/2019 - 09/2000
4Alendronate (Alendronate Sodium)FDA LinkGeneric
11/2019 - 09/2000
4Immunoglobulin G (IgG)IBA
10/2017 - 07/2000
4CalciumIBA
07/2013 - 01/2000
4Streptozocin (Streptozotocin)FDA Link
01/2013 - 11/2000
4CholesterolIBA
01/2006 - 08/2000
4Interleukin-18 (Interleukin 18)IBA
12/2005 - 10/2001
4Endothelins (Endothelin)IBA
07/2004 - 11/2000
4Histamine (Histamine Dihydrochloride)FDA Link
03/2003 - 01/2000
4Anti-Bacterial Agents (Antibiotics)IBA
01/2003 - 05/2001
4Granulocyte Colony-Stimulating Factor (G-CSF)IBA
05/2001 - 07/2000
4Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2001 - 03/2000
3AlbuminsIBA
12/2018 - 01/2000
3DNA (Deoxyribonucleic Acid)IBA
09/2015 - 01/2001
3Dexamethasone (Maxidex)FDA LinkGeneric
04/2015 - 09/2001
3Brain Natriuretic Peptide (Natrecor)FDA Link
02/2015 - 11/2000
3Warfarin (Coumadin)FDA LinkGeneric
01/2015 - 03/2000
3Dacarbazine (DIC)FDA LinkGeneric
12/2013 - 05/2000
3InterferonsIBA
12/2013 - 09/2001
3Glucose (Dextrose)FDA LinkGeneric
10/2008 - 11/2000
3RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
08/2007 - 08/2001
3Capsules (Microcapsules)IBA
02/2007 - 02/2000
3Adrenal Cortex Hormones (Corticosteroids)IBA
10/2005 - 05/2000

Therapy/Procedure

29Therapeutics
04/2019 - 01/2000
9Drug Therapy (Chemotherapy)
11/2014 - 01/2001
6Vascular Access Devices (Arterial Line)
07/2010 - 10/2006
4Operative Surgical Procedures
02/2007 - 08/2000
3Anesthesia
04/2015 - 03/2000
3Castration
12/2013 - 06/2000
3Aftercare (After-Treatment)
01/2007 - 09/2000
3Gastrectomy
05/2004 - 07/2000